LCN2 deficiency protects against alcohol- and diet-induced liver inflammation and injury in mouse models of NASH [60,61], and LCN2-deficient mice are refractory to obesity-induced insulin resistance, adipose tissue inflammation and endothelial dysfunction [62]. Here, LCN2 is linked to metabolic dysfunction-associated steatohepatitis.